Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 5/2016

01-05-2016 | Allergic Skin Diseases (L Fonacier, Section Editor)

Skin Biomes

Authors: N. Fyhrquist, A. Salava, P. Auvinen, A. Lauerma

Published in: Current Allergy and Asthma Reports | Issue 5/2016

Login to get access

Abstract

The cutaneous microbiome has been investigated broadly in recent years and some traditional perspectives are beginning to change. A diverse microbiome exists on human skin and has a potential to influence pathogenic microbes and modulate the course of skin disorders, e.g. atopic dermatitis. In addition to the known dysfunctions in barrier function of the skin and immunologic disturbances, evidence is rising that frequent skin disorders, e.g. atopic dermatitis, might be connected to a dysbiosis of the microbial community and changes in the skin microbiome. As a future perspective, examining the skin microbiome could be seen as a potential new diagnostic and therapeutic target in inflammatory skin disorders.
Literature
1.•
Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676–84. Comprehensive review about the cutaneous microbiome and microbe-microbe dynamics.CrossRefPubMedPubMedCentral
2.••
Belkaid Y, Segre JA. 2014. Science. 2014;346:954–9. Good and recent review about host-microbe interplay.CrossRefPubMed
3.••
Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9:244–53. Up-to date article about new methods exploring the skin microbiome and future prespectives.CrossRefPubMedPubMedCentral
4.•
Oh J, Byrd AL, Deming C, Conlan S, Program NCS, Kong HH, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 2014;514:59–64.CrossRefPubMedPubMedCentral
5.
Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell Metab. 2014;20:719–30.CrossRefPubMedPubMedCentral
6.
Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014;14:289–301.CrossRefPubMed
7.
Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.CrossRefPubMedPubMedCentral
8.
Wilson M. Microbial inhabitants of humans: their ecology and role in health and disease. 2005. Cambridge University Press.
9.
10.
Scott JC, Sahl HG, Carne A, Tagg JR. Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett. 1992;72:97–102.CrossRefPubMed
11.
Otto M, Sussmuth R, Vuong C, Jung G, Gotz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 1999;450:257–62.CrossRefPubMed
12.
Mazmanian SK, Round JL, Kasper D. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620–5.CrossRefPubMed
13.
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–6.CrossRefPubMedPubMedCentral
14.
Ushijima T, Takahashi M, Ozaki Y. Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase-negative Staphylococcus on normal human skin. Can J Microbiol. 1984;30:647–52.CrossRefPubMed
15.
Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, et al. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One. 2013;8:e55380.CrossRefPubMedPubMedCentral
16.
Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang CM. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol. 2010;130:985–94.CrossRefPubMedPubMedCentral
17.•
Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130:2211–21. Good study about the cutaneous microbe-microbe interplay and dynamics.CrossRefPubMedPubMedCentral
18.
Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2011;131:382–90.CrossRefPubMed
19.
Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15:1377–82.CrossRefPubMedPubMedCentral
20.
Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci. 2013;110:15061–6.CrossRefPubMedPubMedCentral
21.
Yang Y, Torchinsky MB, Gobert M, Xiong H, Xu M, Linehan JL, et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature. 2014;510:152–6.CrossRefPubMedPubMedCentral
22.••
Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol. 2013;13(5):514–20. Recent and well-done review about cutaneous microbiome and inflammatory skin diseases.CrossRefPubMed
23.
Seite S, Bieber T. Barrier function and microbiotic dysbiosis in atopic dermatitis. Clin Cosmet Investig Dermatol. 2015;15(8):479–83.CrossRef
24.•
Salava A, Lauerma A. Role of the skin microbiome in atopic dermatitis. Clin Transl Allergy. 2014;17(4):33. Comprehensive and recent review about the cutaneous microbiome and atopic dermatitis.CrossRef
25.•
Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–9. Good clinical study about the microbiome dynamics in atopic dermatitis and decrease of microbial diversity during flares of the skin disease.CrossRefPubMedPubMedCentral
26.
Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep. 2015;15(11):65.CrossRefPubMed
27.•
Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346–9. Study showing good examples about the microbe-microbe dynamics and antagonism of commensal bacteria with pathogens.CrossRefPubMed
28.
Baviera G, Leoni MC, Capra L, Cipriani F, Longo G, Maiello N, et al. Microbiota in healthy skin and in atopic eczema. Biomed Res Int. 2014;2014:436921.CrossRefPubMedPubMedCentral
29.
Powers CE, McShane DB, Gilligan PH, Burkhart CN, Morrell DS. Microbiome and pediatric atopic dermatitis. J Dermatol. 2015;42(12):1137–42.CrossRefPubMed
30.
Salava A, Aho V, Pereira P, Koskinen K, Paulin L, Auvinen P, et al. Skin microbiome in melanomas and melanocytic nevi. Eur J Dermatol. 2016;26(1):49–55.PubMed
Metadata
Title
Skin Biomes
Authors
N. Fyhrquist
A. Salava
P. Auvinen
A. Lauerma
Publication date
01-05-2016
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 5/2016
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-016-0618-5

Other articles of this Issue 5/2016

Current Allergy and Asthma Reports 5/2016 Go to the issue

Pediatric Allergy and Immunology (WK Dolen, Section Editor)

Food Allergy: Our Evolving Understanding of Its Pathogenesis, Prevention, and Treatment

Food Allergy (T Green, Section Editor)

Quality of Life Among Food Allergic Patients and Their Caregivers

Immune Deficiency and Dysregulation (DP Huston and C Kuo, Section Editors)

Gene Therapy for the Treatment of Primary Immune Deficiencies

Rhinosinusitis (J Mullol, Section Editor)

Olfaction in Chronic Rhinosinusitis

Pediatric Allergy and Immunology (WK Dolen, Section Editor)

Peanut Allergy: New Developments and Clinical Implications

Immune Deficiency and Dysregulation (DP Huston and C Kuo, Section Editors)

Epigenetic Dysfunction in Turner Syndrome Immune Cells